why choose us

First received: October 09, 2022

Clinical Trial: Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Autoimmune Diseases

Study Type: INTERVENTIONAL


Official Title: Effects of Immunomodulatory Therapy on Gonadal Function in Women With Autoimmune Premature Ovarian Insufficiency

Brief Summary: Title: Effects of immunomodulatory therapy on gonadal function in women with autoimmune premature ovarian insufficiency (POI)Trial objectives and purpose: To study if rituximab therapy can improve ovarian response to gonadotropin stimulation and menstrual function in women with autoimmune POI.Treatment: Controlled ovarian hyperstimulation before and four months after an infusion of 1-gram rituximab (Mabthera®) twice with two weeks interval.Follow-up period 12 months after infusion.Primary outcome: Number of antral…

Read more